Bank Of America Corp Adaptimmune Therapeutics PLC Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Bank Of America Corp holds 4,653,325 shares of ADAP stock, worth $5.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,653,325

Previous 4,667,787 0.31%

Holding current value

$5.17 Million

Previous $7.38 Million 38.17%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.83 - $1.47 $12,003 - $21,259	-14,462 Reduced 0.31%	4,653,325 $4.56 Million
Q1 2024 May 15, 2024	SELL	$0.7 - $1.75 $21,116 - $52,792	-30,167 Reduced 0.64%	4,667,787 $7.38 Million
Q4 2023 Feb 14, 2024	SELL	$0.43 - $0.79 $199 - $367	-465 Reduced 0.01%	4,697,954 $3.71 Million
Q2 2023 Aug 14, 2023	SELL	$0.9 - $1.51 $632,961 - $1.06 Million	-703,291 Reduced 13.02%	4,698,419 $4.32 Million
Q1 2023 May 12, 2023	BUY	$1.06 - $2.16 $702,883 - $1.43 Million	663,098 Added 13.99%	5,401,710 $5.89 Million
Q4 2022 Feb 10, 2023	BUY	$1.05 - $2.53 $3.89 Million - $9.37 Million	3,703,418 Added 357.75%	4,738,612 $6.92 Million
Q3 2022 Nov 14, 2022	BUY	$1.06 - $2.41 $46,375 - $105,437	43,750 Added 4.41%	1,035,194 $1.11 Million
Q2 2022 Aug 12, 2022	BUY	$1.33 - $2.28 $621,418 - $1.07 Million	467,232 Added 89.13%	991,444 $1.69 Million
Q1 2022 May 16, 2022	SELL	$1.73 - $4.06 $24,045 - $56,429	-13,899 Reduced 2.58%	524,212 $1.08 Million
Q4 2021 Feb 08, 2022	SELL	$3.5 - $5.68 $678,944 - $1.1 Million	-193,984 Reduced 26.5%	538,111 $2.02 Million
Q3 2021 Nov 15, 2021	BUY	$3.44 - $6.37 $2.47 Million - $4.58 Million	719,108 Added 5537.14%	732,095 $3.79 Million
Q2 2021 Sep 13, 2021	BUY	$3.86 - $5.78 $50,129 - $75,064	12,987 New	12,987 $55,000

Others Institutions Holding ADAP

# of Institutions

Shares Held

152M

Call Options Held

78.5K

Put Options Held

36.5K

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $181M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Adaptimmune Therapeutics PLC Transaction History